{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T22:01:53Z","timestamp":1791669713254,"version":"4.3.4"},"reference-count":52,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["75N910D00024"],"award-info":[{"award-number":["75N910D00024"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["75N91019F00130"],"award-info":[{"award-number":["75N91019F00130"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jaip.2021.12.031","type":"journal-article","created":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T20:41:01Z","timestamp":1642020061000},"page":"2424-2435.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Elevated Basal Serum Tryptase: Disease Distribution and Variability in a Regional Health System"],"prefix":"10.1016","volume":"10","author":[{"given":"Aubri M.","family":"Waters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun J.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L.","family":"Weskamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allyson","family":"Mateja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan E.","family":"Kachur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan J.","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan A.","family":"Boggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2021.12.031_bib1","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/ng.3696","article-title":"Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number","volume":"48","author":"Lyons","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaip.2021.12.031_bib2","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2021.12.031_bib3","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1182\/blood-2003-01-0006","article-title":"Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness","volume":"101","author":"Klion","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2021.12.031_bib4","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1365-2362.2009.02184.x","article-title":"Elevated tryptase levels selectively cluster in myeloid neoplasms: a novel diagnostic approach and screen marker in clinical haematology","volume":"39","author":"Sperr","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jaip.2021.12.031_bib5","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1182\/blood.V98.7.2200","article-title":"Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia","volume":"98","author":"Sperr","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2021.12.031_bib6","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1080\/10428190290021470","article-title":"Serum tryptase measurements in patients with myelodysplastic syndromes","volume":"43","author":"Sperr","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jaip.2021.12.031_bib7","first-page":"282","article-title":"Serum tryptase levels and markers of renal dysfunction in a population with chronic kidney disease","volume":"23","author":"Sirvent","year":"2010","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.jaip.2021.12.031_bib8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s10620-018-5298-7","article-title":"Elevated tryptase in EoE is an independent phenomenon associated with extra-esophageal symptoms","volume":"64","author":"Kutty","year":"2019","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jaip.2021.12.031_bib9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/imm.12197","article-title":"Tryptase is a candidate autoantigen in rheumatoid arthritis","volume":"142","author":"Guo","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.jaip.2021.12.031_bib10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1365-2249.2010.04287.x","article-title":"Raised tryptase without anaphylaxis or mastocytosis: heterophilic antibody interference in the serum tryptase assay","volume":"163","author":"Sargur","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaip.2021.12.031_bib11","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.jaci.2005.07.023","article-title":"False-elevated serum tryptase assay result caused by heterophilic antibodies","volume":"116","author":"van Toorenenbergen","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.12.031_bib12","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2340\/00015555-1486","article-title":"The utility of serum tryptase as a marker in chronic spontaneous urticaria","volume":"93","author":"Siles","year":"2013","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaip.2021.12.031_bib13","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1111\/j.1365-2222.2010.03582.x","article-title":"Serum total tryptase levels are increased in patients with active chronic urticaria","volume":"40","author":"Ferrer","year":"2010","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2021.12.031_bib14","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jaci.2021.06.017","article-title":"Hereditary alpha tryptasemia is not associated with specific clinical phenotypes","volume":"149","author":"Chollet","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.12.031_bib15","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaci.2020.06.035","article-title":"Heritable risk for severe anaphylaxis associated with increased \u03b1-tryptase-encoding germline copy number at TPSAB1","volume":"147","author":"Lyons","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.12.031_bib16","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1182\/blood.2020006157","article-title":"Hereditary \u03b1 tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis","volume":"137","author":"Greiner","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2021.12.031_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2015.04.024","article-title":"Assessment of clinical findings, tryptase levels, and bone marrow histopathology in the management of pediatric mastocytosis","volume":"136","author":"Carter","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.12.031_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2021.08.007","article-title":"Defining baseline variability of serum tryptase levels improves accuracy in identifying anaphylaxis","volume":"149","author":"Mateja","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.12.031_bib19","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1515\/CCLM.2010.124","article-title":"Factors influencing serum total tryptase concentrations in a general adult population","volume":"48","author":"Gonzalez-Quintela","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jaip.2021.12.031_bib20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000327535","article-title":"Determinants of serum tryptase in a general population: the relationship of serum tryptase to obesity and asthma","volume":"157","author":"Fenger","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2021.12.031_bib21","unstructured":"Defense Health Agency Department of Defense. National Capital Region Market. Health.mil. National Capital Region Market. Accessed November 15, 2021. https:\/\/www.health.mil\/About-MHS\/OASDHA\/Defense-Health-Agency\/NCR-Medical-Directorate"},{"key":"10.1016\/j.jaip.2021.12.031_bib22","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1016\/j.jaip.2020.05.057","article-title":"Hereditary alpha-tryptasemia: UK prevalence and variability in disease expression","volume":"8","author":"Robey","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.12.031_bib23","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.anai.2021.01.016","article-title":"Hereditary alpha-tryptasemia in 101 patients with mast cell activation-related symptomatology including anaphylaxis","volume":"126","author":"Giannetti","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.12.031_bib24","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.jaci.2006.02.042","article-title":"Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report","volume":"117","author":"Klion","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.12.031_bib25","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jaci.2012.02.019","article-title":"Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes","volume":"130","author":"Valent","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.12.031_bib26","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1182\/blood-2016-09-731893","article-title":"2016 updated WHO classification and novel emerging treatment concepts","volume":"129","author":"Valent","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2021.12.031_bib27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000328760","article-title":"Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal","volume":"157","author":"Valent","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2021.12.031_bib28","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1053\/j.gastro.2018.07.009","article-title":"Updated international consensus diagnostic criteria for eosinophilic esophagitis: proceedings of the AGREE conference","volume":"155","author":"Dellon","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2021.12.031_bib29","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/all.13397","article-title":"The EAACI\/GA2LEN\/EDF\/WAO guideline for the definition, classification, diagnosis and management of urticaria","volume":"73","author":"Zuberbier","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.12.031_bib30","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaip.2021.12.031_bib31","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.rmed.2014.09.011","article-title":"Clinical implications of correlation between peripheral eosinophil count and serum levels of IL-5 and tryptase in acute eosinophilic pneumonia","volume":"108","author":"Jhun","year":"2014","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2021.12.031_bib32","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1056\/NEJMoa1513098","article-title":"Efficacy and safety of midostaurin in advanced systemic mastocytosis","volume":"374","author":"Gotlib","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2021.12.031_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2018.06.003","article-title":"Midostaurin in patients with indolent systemic mastocytosis: an open-label phase 2 trial","volume":"142","author":"van Anrooij","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.12.031_bib34","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.anai.2021.08.009","article-title":"Clinical relevance of inherited genetic differences in human tryptases: hereditary alpha-tryptasemia and beyond","volume":"127","author":"Glover","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.12.031_bib35","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.aller.2014.05.002","article-title":"Clinical characteristics and risk profile of patients with elevated baseline serum tryptase","volume":"42","author":"Fellinger","year":"2014","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.jaip.2021.12.031_bib36","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.iac.2014.01.003","article-title":"Epidemiology, prognosis, and risk factors in mastocytosis","volume":"34","author":"Brockow","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2021.12.031_bib37","doi-asserted-by":"crossref","first-page":"473","DOI":"10.7326\/M16-0273","article-title":"Trends in prevalence of chronic kidney disease in the united states","volume":"165","author":"Murphy","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaip.2021.12.031_bib38","article-title":"Optimizing value in the evaluation of chronic spontaneous urticaria: a cost-effectiveness analysis","volume":"8","author":"Shaker","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.12.031_bib39","unstructured":"American Academy of Allergy, Asthma, and Immunology. Choosing Wisely. Accessed August 10, 2021. https:\/\/www.choosingwisely.org\/societies\/american-academy-of-allergy-asthma-immunology\/"},{"key":"10.1016\/j.jaip.2021.12.031_bib40","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/ndt\/gfp628","article-title":"Effect of oral cromolyn sodium on CKD-associated pruritus and serum tryptase level: a double-blind placebo-controlled study","volume":"25","author":"Vessal","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jaip.2021.12.031_bib41","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaci.2021.02.043","article-title":"Routine KIT p.D816V screening identifies clonal mast cell disease in Hymenoptera allergic patients regularly missed using baseline tryptase levels alone","volume":"148","author":"\u0160elb","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.12.031_bib42","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.jaci.2011.01.045","article-title":"Clinical utility of the chronic urticaria index","volume":"127","author":"Biagtan","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.12.031_bib43","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.jaci.2013.11.039","article-title":"Mendelian inheritance of elevated serum tryptase associated with atopy and connective tissue abnormalities","volume":"133","author":"Lyons","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.12.031_bib44","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00011-009-0044-4","article-title":"Inhibition of CD203c membrane up-regulation in human basophils by high dilutions of histamine: a controlled replication study","volume":"58","author":"Chirumbolo","year":"2009","journal-title":"Inflamm Res"},{"key":"10.1016\/j.jaip.2021.12.031_bib45","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cell.2019.09.009","article-title":"An allosteric anti-tryptase antibody for the treatment of mast cell-mediated severe asthma","volume":"179","author":"Maun","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.jaip.2021.12.031_bib46","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.jaip.2020.01.055","article-title":"Platelet-derived growth factor receptor-alpha-positive myeloid neoplasm presenting as eosinophilic gastrointestinal disease","volume":"8","author":"Constantine","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.12.031_bib47","first-page":"82718","article-title":"Single-organ and multisystem hypereosinophilic syndrome patients with gastrointestinal manifestations share common characteristics","author":"Kuang","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.12.031_bib48","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1016\/j.jaip.2020.05.049","article-title":"The role of bone marrow evaluation in clinical allergy and immunology practice: when and why","volume":"8","author":"Boggs","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.12.031_bib49","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jaci.2019.08.023","article-title":"AAAAI Mast Cell Disorders Committee Work Group Report: mast cell activation syndrome (MCAS) diagnosis and management","volume":"144","author":"Weiler","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.12.031_bib50","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000501079","article-title":"Why the 20%\u00a0+ 2 tryptase formula is a diagnostic gold standard for severe systemic mast cell activation and mast cell activation syndrome","volume":"180","author":"Valent","year":"2019","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2021.12.031_bib51","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1399-3038.2011.01166.x","article-title":"Total serum tryptase levels are higher in young infants","volume":"22","author":"Belhocine","year":"2011","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2021.12.031_bib53","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.iac.2018.04.003","article-title":"Hereditary alpha tryptasemia: genotyping and associated clinical features","volume":"38","author":"Lyons","year":"2018","journal-title":"Immunol Allergy Clin North Am"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219822000034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219822000034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:52:34Z","timestamp":1778853154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219822000034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S2213219822000034"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2021.12.031","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated Basal Serum Tryptase: Disease Distribution and Variability in a Regional Health System","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2021.12.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}